Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious.

In this episode of "The Top Line," recorded at Fierce Pharma Week in Philadelphia, Freda Lewis-Hall, M.D., joins us to share how she has worked to put a human face on the industry. A psychiatrist, longtime patient advocate and former Pfizer chief medical officer, she explains why listening must come before messaging, how AI and omnichannel outreach can help or harm patient trust and why rebuilding credibility starts one conversation at a time.

To learn more about the topics in this episode: 
TV ads close to overtaking doctors as consumers' primary source for learning about new meds: survey
Pharma's reputation is stable-ish. Will that survive Trump 2.0?
ABPI finds familiarity breeds trust, supporting push for industry-healthcare collaborations
Doctor Mike calls on healthcare, pharma leaders to lean into social media to rebuild trust with patients

Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious.
In this episode of "The Top Line," recorded at Fierce Pharma Week in Philadelphia, Freda Lewis-Hall, M.D., joins us to share how she has worked to put a human face on the industry. A psychiatrist, longtime patient advocate and former Pfizer chief medical officer, she explains why listening must come before messaging, how AI and omnichannel outreach can help or harm patient trust and why rebuilding credibility starts one conversation at a time.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercepharma.com/marketing/tv-ads-close-overtaking-doctors-consumers-primary-source-learning-about-new-meds-survey">TV ads close to overtaking doctors as consumers' primary source for learning about new meds: survey</a></li>
<li><a href="https://www.fiercepharma.com/marketing/pharmas-reputation-stable-ish-will-survive-trump-20">Pharma's reputation is stable-ish. Will that survive Trump 2.0?</a></li>
<li><a href="https://www.fiercepharma.com/marketing/abpi-finds-familiarity-breeds-trust-supporting-push-industry-healthcare-collaborations">ABPI finds familiarity breeds trust, supporting push for industry-healthcare collaborations</a></li>
<li><a href="https://www.fiercepharma.com/marketing/doctor-mike-calls-healthcare-pharma-leaders-lean-social-media-rebuild-trust">Doctor Mike calls on healthcare, pharma leaders to lean into social media to rebuild trust with patients</a></li>
</ul>

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement